Editas Medicine (EDIT) Change in Account Payables (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Change in Account Payables data on file, last reported at -$3.6 million in Q3 2025.

• On a quarterly basis, Change in Account Payables fell 183.97% year-over-year to -$3.6 million in Q3 2025; TTM through Sep 2025 was -$9.3 million, a 540.25% decrease from a year earlier, with the FY2024 full-year figure at -$2.3 million, down 53.22% from the prior year.
• Change in Account Payables for Q3 2025 stood at -$3.6 million, down from $1.3 million in the prior quarter.
• Over the last five years, Change in Account Payables for EDIT reached as high as $7.4 million in Q2 2024 and fell as low as -$7.0 million in Q4 2024.
• Historically, Change in Account Payables has averaged -$151526.3 across 5 years, with a median of -$229000.0 in 2022.
• Across the five-year window, Change in Account Payables tumbled 196.29% in 2023 and jumped 1161.95% in 2024, its largest moves.
• Year by year, Change in Account Payables stood at $1.8 million in 2021, then surged by 46.49% to $2.7 million in 2022, then tumbled by 196.29% to -$2.6 million in 2023, then plunged by 169.81% to -$7.0 million in 2024, then surged by 49.12% to -$3.6 million in 2025.
• Per Business Quant data, the three most recent Change in Account Payables figures were -$3.6 million in Q3 2025, $1.3 million in Q2 2025, and -$27000.0 in Q1 2025.